Public Pharma: still a missing debate in mainstream academia
Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
29 years without Jonas Salk: against the normalization of the absurd
Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry
Presence of dengue in Europe raises public health concerns
An increase in local dengue transmissions reported by EU public health agencies has raised concerns about outbreak risks as climate change makes the region more suitable for Aedes mosquitoes
Public pharma infrastructure could give the world access to a treasure trove of medicines
Health activists and scientists in Europe met to develop strategies to build regional public pharmaceutical infrastructure as pandemic lessons seems lost on governments and producers
Public pharma for Europe, a game-changer for access to medicines
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
- Panamanian workers mobilize against Social Security privatization
- Student protests grow in Serbia
- NATO countries control over 80% of global arms exports amid rising conflicts
- Dr. Oz’s nomination fuels fears for crucial health programs
- Columbia expels and sanctions pro-Palestine students amid increased pressure from Trump administration
